Sign In
Get Clay Free →

Suggestions

    David Fabrizio

    VP, Translational Strategy at Foundation Medicine

    David Fabrizio is an experienced professional specializing in next-generation sequencing methods to uncover new insights into how cancer responds to various therapies. With a strong educational background in Molecular Biology and Biological Sciences from the University of Vermont, he has held key leadership roles in renowned organizations such as Foundation Medicine.

    At Foundation Medicine, David has served as the Vice President of Translational Strategy, showcasing his strategic acumen and deep understanding of the translational aspects of cancer research and treatment. His prior role as the Vice President of Product Development underscores his proficiency in driving the development of innovative medical solutions.

    Having also led the Development Franchise for Solid Tumors & Immuno-oncology, David has demonstrated his expertise in oncology research. His tenure as the Leader of Cancer Immunotherapy highlights his contributions to advancing cancer treatment methodologies. Furthermore, his experience as a Senior Scientist in Immuno-oncology signifies his hands-on involvement in cutting-edge research initiatives.

    Before his tenure at Foundation Medicine, David held significant positions at esteemed companies such as AbVitro Inc. and Adnexus, a subsidiary of Bristol-Myers Squibb. His time at Harvard Medical School at Massachusetts General Hospital further enriched his knowledge and expertise in the medical field.

    David Fabrizio
    Add to my network

    Location

    Greater Boston